Cytori Therapeutics Inc Warrant
CYTXW
CYTXW was delisted on the 14th of December, 2018.
2 hedge funds and large institutions have $1K invested in Cytori Therapeutics Inc Warrant in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
91% less capital invested
Capital invested by funds: $11K → $1K (-$10K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$29.1K |
CYTXW Hedge Fund Activity: Q1 2018 in Review
2 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q1 2018, worth a combined $1K — down 91% from $11K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CYTXW and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $29.1K sold.
- 2 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q1 2018, down from 4 in Q4 2017.
- Funds reported $1K of Cytori Therapeutics Inc Warrant stock for Q1 2018, down 91% quarter-over-quarter.
- 1 fund opened new Cytori Therapeutics Inc Warrant positions in Q1 2018 and 3 closed out, a net change of -2 holders.
- The largest Cytori Therapeutics Inc Warrant seller in Q1 2018 was Sabby Management, an estimated $29.1K sold.
Based on aggregated 13F filings for Q1 2018.